Lorna Rothery discussed the challenges associated with the safe transfusion and supply of blood with Dr Evan M. Bloch, focusing on where future efforts to reduce transfusion-transmitted infections should be directed.
Prof Colin J Suckling OBE DSc FRSE, Research Professor of Chemistry at the University of Strathclyde imparts his expertise on the worldwide research challenge of infectious disease and argues that this is both diverse and everywhere
SocialDiabetes is participating in two NHS testbed projects to pilot the future of digital health and patient-centric diabetes care, as Ikuska Sanz, the firm’s Director of Operations describes
Regina Fluhrer from the LMU & DZNE in Munich explains an aspect of health research that concerns how proteases embedded in cellular membranes hydrolyse other proteins and the challenges they must overcome.
Prof Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH shares his views on data-based solutions for diabetes.
The National Academy of Sciences (PNAS) has published new research which reveals that Huntington's Disease may take affect in people much earlier on in life than originally expected and that a new drug may be paramount in controlling the disease.
Ken Arnold, Creative Director at Wellcome explains what contagious cities are and the extent to which they are considered to be cultural programming in a policy context
Public Health England is urging students to get MenACWY and MMR vaccines before the start of the new college or university year to ensure they're protected against deadly diseases
New data published by Public Health England (PHE) show that deaths from hepatitis C-related end-stage liver disease have fallen by 11% in 2017 compared to the previous year
The work of Vytenis Andriukaitis, European Commissioner for Health & Food Safety, with responsibility for modernising health policy, building up knowledge and tackling preventable diseases
Professor John Wilding from the University of Liverpool charts priorities for improving patient care in the UK when it comes to the prevalent condition, Type 2 diabetes
Isabel Proaño Gómez, Communications Manager at European Federation of Allergies and Airways Diseases Patients’ Associations (EFA) explains why air matters, for everybody, everywhere (H2)
Helen McShane, Professor of Vaccinology at The Jenner Institute, University of Oxford reveals the current status of tuberculosis vaccine development in the world today.
